<DOC>
	<DOC>NCT01887405</DOC>
	<brief_summary>The purpose of the study is to demonstrate non-inferiority of Jext compared with EpiPen for the proportion of subjects with a successful self-injection. And to evaluate and compare the handling characteristics of two auto-injectors (Jext and EpiPen).</brief_summary>
	<brief_title>Comparative Evaluation of Handling Characteristics of Two Adrenaline Autoinjectors,EpiPen in Comparison With Jext</brief_title>
	<detailed_description />
	<mesh_term>Epinephrine</mesh_term>
	<mesh_term>Racepinephrine</mesh_term>
	<mesh_term>Epinephryl borate</mesh_term>
	<criteria>Written informed consent obtained before entering the study 1 Prescription of EpiPen or AnaPen for at least 2 months Age â‰¥16 years Body weight &gt;50 kg Subject willing and able to comply with study protocol Any of the following concomitant diseases: cardiovascular disease, e.g. arrhythmias or signs of coronary atherosclerosis, heart failure, uncontrolled hypertension, uncontrolled diabetes mellitus, cancer, hyperthyroidism, severe renal impairment Known bloodborn infection, e.g. hepatitis and/or HIV Concomitant treatment with medication which may potentiate the effect of adrenaline, e.g. catecholOmethyl transferase (COMT) inhibitors, monoamine oxidase (MAO) inhibitors and tricyclic antidepressants Pregnancy Being immediate family of the investigator or study staff, defined as the investigator's/staff's spouse, parent, child, grandparent or grandchild</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Adrenaline</keyword>
	<keyword>Auto-injector</keyword>
	<keyword>Jext</keyword>
	<keyword>Epipen</keyword>
</DOC>